THE GROWTH AND CHARACTERIZATION OF CRYSTALS OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) REVERSE-TRANSCRIPTASE

被引:11
|
作者
JONES, EY
STUART, DI
GARMAN, EF
GRIEST, R
PHILLIPS, DC
TAYLOR, GL
MATSUMOTO, O
DARBY, G
LARDER, B
LOWE, D
POWELL, K
PURIFOY, D
ROSS, CK
SOMERS, D
TISDALE, M
STAMMERS, DK
机构
[1] LAB MOLEC BIOPHYS,OXFORD OX1 3QU,ENGLAND
[2] WELLCOME RES LABS,DEPT CELL BIOL,BECKENHAM BR3 3BS,KENT,ENGLAND
[3] TOKYO INST TECHNOL,DEPT LIFE SCI,YOKOHAMA,KANAGAWA 227,JAPAN
基金
英国医学研究理事会;
关键词
D O I
10.1016/0022-0248(93)90032-R
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
Extensive studies on the crystallization of HIV-1 reverse transcriptase (RT) have yielded several crystal forms, two of which show diffraction to minimum Bragg spacings of 6 angstrom or better. Type 1 crystals belong to the space group P2(1)2(1)2(1) with unit cell dimensions a = 147 angstrom, b = 190 angstrom and c = 182 angstrom. Crystal density measurements indicate a very high crystal solvent content of 77% consistent with the presence of two RT heterodimers (66k/51k) per crystallographic asymmetric unit. These crystals are suitable for a low resolution determination of the apoenzyme structure. The second well ordered crystal form (space group P4(2)22 with unit cell dimensions a = b = 120 angstrom, c = 320 angstrom) results from the co-crystallization of RT heterodimer and a double-stranded DNA oligonucleotide. Crystal density measurements again yield a relatively high value for the solvent content (70%; one RT heterodimer per crystallographic asymmetric unit) and elemental analysis indicates that one DNA oligonucleotide is associated with each RT heterodimer. This is consistent with each heterodimer possessing a single, competent, active site.
引用
收藏
页码:261 / 269
页数:9
相关论文
共 50 条
  • [41] DIVALENT-CATION MODULATION OF THE RIBONUCLEASE FUNCTIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    CIRINO, NM
    CAMERON, CE
    SMITH, JS
    RAUSCH, JW
    ROTH, MJ
    BENKOVIC, SJ
    LEGRICE, SFJ
    BIOCHEMISTRY, 1995, 34 (31) : 9936 - 9943
  • [42] ENGINEERING OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REVERSE-TRANSCRIPTASE GENE TO PREVENT DIMERIZATION OF THE EXPRESSED CHIMERIC PROTEIN - PURIFICATION AND CHARACTERIZATION OF A MONOMERIC HIV-1 REVERSE-TRANSCRIPTASE
    SHARMA, SK
    BASU, A
    FAN, NS
    EVANS, DB
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 1994, 19 : 155 - 167
  • [43] SENSITIVITY RESISTANCE PROFILE OF A SIMIAN IMMUNODEFICIENCY VIRUS CONTAINING THE REVERSE-TRANSCRIPTASE GENE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) TOWARD THE HIV-1-SPECIFIC NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS
    BALZARINI, J
    WEEGER, M
    CAMARASA, MJ
    DECLERCQ, E
    UBERLA, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 211 (03) : 850 - 856
  • [44] FIDELITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I REVERSE-TRANSCRIPTASE IN COPYING NATURAL RNA
    HUBNER, A
    KRUHOFFER, M
    GROSSE, F
    KRAUSS, G
    JOURNAL OF MOLECULAR BIOLOGY, 1992, 223 (03) : 595 - 600
  • [45] HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE - EFFECT OF PRIMER LENGTH ON TEMPLATE-PRIMER BINDING
    REARDON, JE
    FURFINE, ES
    CHENG, N
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (21) : 14128 - 14134
  • [46] SIMIAN IMMUNODEFICIENCY VIRUS REVERSE-TRANSCRIPTASE - PURIFICATION AND PARTIAL CHARACTERIZATION
    KRAUS, G
    BEHR, E
    BAIER, M
    KONIG, H
    KURTH, R
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 192 (01): : 207 - 213
  • [47] COMPARISON OF ANTIGEN-ASSAY AND REVERSE-TRANSCRIPTASE ASSAY FOR DETECTING HUMAN-IMMUNODEFICIENCY-VIRUS IN CULTURE
    FEORINO, P
    FORRESTER, B
    SCHABLE, C
    WARFIELD, D
    SCHOCHETMAN, G
    JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (12) : 2344 - 2346
  • [48] INTERACTION OF C-TERMINAL SEQUENCES OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE WITH TEMPLATE PRIMER
    DEVICO, AL
    COPELAND, TD
    OROSZLAN, S
    GALLO, RC
    SARNGADHARAN, MG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (11) : 6774 - 6779
  • [49] ERROR-PRONE DNA POLYMERIZATION BY HUMAN IMMUNODEFICIENCY VIRUS (HIV) REVERSE-TRANSCRIPTASE
    PRESTON, BD
    LOEB, LA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 443 - 443
  • [50] HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE DISPLAYS A PARTIALLY PROCESSIVE 3' TO 5' ENDONUCLEASE ACTIVITY
    DESTEFANO, JJ
    BUISER, RG
    MALLABER, LM
    BAMBARA, RA
    FAY, PJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (36) : 24295 - 24301